Haffkine to start manufacturing 22.8 crore Covaxin doses from February 2022 Nation Haffkine to start manufacturing 22.8 crore Covaxin doses from February 2022 News Analysis India 3 years ago Express News Service MUMBAI: Mumbai based Haffkine Biopharma may not be in position to contribute to the Centre’s ambitious projection of nearly 55 crore...Read More